Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study.

BACKGROUND Several studies using echocardiography identified epicardial adipose tissue (EPI) as an important cardiometabolic risk marker. However, validation compared with magnetic resonance imaging (MRI) or computed tomography has not been performed. Moreover, pericardial adipose tissue (PERI) has recently been shown to have some correlation with cardiovascular disease risk factors. The aims of this study were to validate echocardiographic analyses compared with MRI and to evaluate which cardiac fat depot (EPI or PERI) is the most appropriate cardiovascular risk marker. METHODS Forty-nine healthy subjects were studied (age range, 25-68 years; body mass index, 21-40 kg/m(2)), and PERI and EPI fat depots were measured using echocardiography and MRI. Findings were correlated with MRI visceral fat and subcutaneous fat, blood pressure, insulin sensitivity, triglycerides, cholesterol, insulin, glucose, and 10-year coronary heart disease risk. RESULTS Most cardiac fat was constituted by PERI (about 77%). PERI thickness by echocardiography was well correlated with MRI area (r = 0.36, P = .009), and independently of the technique used for quantification, PERI was correlated with body mass index, waist circumference, visceral fat, subcutaneous fat, blood pressure, insulin sensitivity, triglycerides, cholesterol, glucose, and coronary heart disease risk. On the contrary, EPI thicknesses correlated only with age did not correlate significantly with MRI EPI areas, which were found to correlate with age, body mass index, subcutaneous fat, and hip and waist circumferences. CONCLUSIONS Increased cardiac fat in the pericardial area is strongly associated with features of the metabolic syndrome, whereas no correlation was found with EPI, indicating that in clinical practice, PERI is a better cardiometabolic risk marker than EPI.

[1]  E. Picano Sustainability of medical imaging , 2004, BMJ : British Medical Journal.

[2]  Moyses Szklo,et al.  The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2009, The American journal of clinical nutrition.

[3]  F. Leonetti,et al.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. , 2003, Obesity research.

[4]  E. Picano,et al.  Cumulative patient effective dose in cardiology. , 2008, The British journal of radiology.

[5]  H. Willens,et al.  Echocardiographic epicardial fat: a review of research and clinical applications. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  Udo Hoffmann,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[7]  F. Leonetti,et al.  Epicardial adipose tissue and insulin resistance in obese subjects. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  V. Positano,et al.  Visceral fat and beta cell function in non-diabetic humans , 2005, Diabetologia.

[9]  F. Leonetti,et al.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.

[10]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[11]  J. Shirani,et al.  Clinical significance of epicardial fat measured using cardiac multislice computed tomography. , 2008, The American journal of cardiology.

[12]  Domenico Corradi,et al.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart , 2005, Nature Clinical Practice Cardiovascular Medicine.

[13]  S W Rabkin,et al.  Epicardial fat: properties, function and relationship to obesity , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[14]  Prashanthan Sanders,et al.  Journal of Cardiovascular Magnetic Resonance Validation of Cardiovascular Magnetic Resonance Assessment of Pericardial Adipose Tissue Volume , 2022 .

[15]  Andrea Mari,et al.  A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test , 2001 .

[16]  C. Pond,et al.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. , 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.

[17]  D. Corradi,et al.  The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[18]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[19]  H. Gerstein,et al.  Relationship of epicardial fat thickness and fasting glucose. , 2008, International journal of cardiology.

[20]  J. Zamorano,et al.  The use of pocket-size imaging devices: a position statement of the European Association of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[21]  S M Grundy,et al.  Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.

[22]  R. Cury,et al.  Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. , 2006, European journal of radiology.

[23]  L. Tanoue Computed Tomography — An Increasing Source of Radiation Exposure , 2009 .

[24]  S. Cha,et al.  Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification? , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  Luigi Landini,et al.  An accurate and robust method for unsupervised assessment of abdominal fat by MRI , 2004, Journal of magnetic resonance imaging : JMRI.

[26]  H. Sacks,et al.  Human epicardial adipose tissue: a review. , 2007, American heart journal.

[27]  M. Lombardi,et al.  Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function , 2004, Hypertension.

[28]  G. Metzger,et al.  Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.

[29]  F. Leonetti,et al.  Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. , 2003, The Journal of clinical endocrinology and metabolism.

[30]  H. Feigenbaum Journal of the American Society of Echocardiography Case Reports with Digital Images , 2005 .

[31]  Arya M. Sharma,et al.  Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. , 2007, The American journal of cardiology.

[32]  F. Leonetti,et al.  Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. , 2007, International journal of cardiology.

[33]  J. Takasu,et al.  Pericardial fat accumulation in men as a risk factor for coronary artery disease. , 2001, Atherosclerosis.

[34]  Arya M. Sharma,et al.  Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. , 2007, Current pharmaceutical design.

[35]  V. Positano,et al.  Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat , 2008, Hypertension.